Embryo Invest ApS: Financial statements 2022
CVR: 42047864
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Embryo Invest ApS (CVR 42047864) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -19,375 and a net result of DKK -7,996,047 compared with DKK 6,293,474 the year before. Equity in the 2022 report amounted to DKK -1,709,773.
- Gross Profit
- DKK -19,375
- Profit/Loss
- DKK -7,996,047
- Equity
- DKK -1,709,773
- Total Assets
- DKK 3,705,307
- Employees
- 0
Official annual report
Keep an eye on Embryo Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Embryo Invest ApS has published its annual report for 2021. Gross profit came to DKK -5,000, and the net result was DKK 6,293,474.
About Embryo Invest ApS
Embryo Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Cathrine Olesen Emborg. The company is owned by Cathrine Olesen Emborg. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,449 and a net result of DKK 840,493 compared with DKK 8,570,903 the year before. Equity in the 2025 report amounted to DKK 12,423,903.
